Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO)

• मुख्य लेखकों: Andreas Pinter (लेखक), Kilian Eyerich (लेखक), Antonio Costanzo (लेखक), Alyssa Garrelts (लेखक), Christopher Schuster (लेखक), Can Mert (लेखक), Anastasia Lampropoulou (लेखक), Konstantinos Fotiou (लेखक), Julia-Tatjana Maul (लेखक), Kim A. Papp (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

AbstractPurpose Currently, in the treatment of moderate-to-severe psoriasis (PsO) there is a lack of evidence demonstrating optimal biologic treatment response with respect to disease duration. The aim of this post-hoc analysis, using real world data from the Psoriasis Study of Health Outcomes (PSoH...